These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 31075204)

  • 21. Squalene containing solid lipid nanoparticles, a promising adjuvant system for yeast vaccines.
    Stelzner JJ; Behrens M; Behrens SE; Mäder K
    Vaccine; 2018 Apr; 36(17):2314-2320. PubMed ID: 29567034
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved vaccine-induced immune responses via a ROS-triggered nanoparticle-based antigen delivery system.
    Liang X; Duan J; Li X; Zhu X; Chen Y; Wang X; Sun H; Kong D; Li C; Yang J
    Nanoscale; 2018 May; 10(20):9489-9503. PubMed ID: 29675543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intranasal immunization with pneumococcal surface protein A in the presence of nanoparticle forming polysorbitol transporter adjuvant induces protective immunity against the Streptococcus pneumoniae infection.
    Kye YC; Park SM; Shim BS; Firdous J; Kim G; Kim HW; Ju YJ; Kim CG; Cho CS; Kim DW; Cho JH; Song MK; Han SH; Yun CH
    Acta Biomater; 2019 May; 90():362-372. PubMed ID: 30922953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-carrier nanoparticles adjuvant modular protein vaccine in a particle-dependent manner.
    Seth A; Ritchie FK; Wibowo N; Lua LH; Middelberg AP
    PLoS One; 2015; 10(3):e0117203. PubMed ID: 25756283
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of a chitosan-modified PLGA nanoparticle vaccine for protection against Escherichia coli K1 caused meningitis in mice.
    Zhang J; Sun H; Gao C; Wang Y; Cheng X; Yang Y; Gou Q; Lei L; Chen Y; Wang X; Zou Q; Gu J
    J Nanobiotechnology; 2021 Mar; 19(1):69. PubMed ID: 33673858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel lipid nanoparticle adjuvant significantly enhances B cell and T cell responses to sub-unit vaccine antigens.
    Swaminathan G; Thoryk EA; Cox KS; Meschino S; Dubey SA; Vora KA; Celano R; Gindy M; Casimiro DR; Bett AJ
    Vaccine; 2016 Jan; 34(1):110-9. PubMed ID: 26555351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques.
    Kasturi SP; Kozlowski PA; Nakaya HI; Burger MC; Russo P; Pham M; Kovalenkov Y; Silveira ELV; Havenar-Daughton C; Burton SL; Kilgore KM; Johnson MJ; Nabi R; Legere T; Sher ZJ; Chen X; Amara RR; Hunter E; Bosinger SE; Spearman P; Crotty S; Villinger F; Derdeyn CA; Wrammert J; Pulendran B
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27928002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PLGA (85:15) nanoparticle based delivery of rL7/L12 ribosomal protein in mice protects against Brucella abortus 544 infection: A promising alternate to traditional adjuvants.
    Singh D; Somani VK; Aggarwal S; Bhatnagar R
    Mol Immunol; 2015 Dec; 68(2 Pt A):272-9. PubMed ID: 26442664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Negatively Charged Carbon Nanohorn Supported Cationic Liposome Nanoparticles: A Novel Delivery Vehicle for Anti-Nicotine Vaccine.
    Zheng H; Hu Y; Huang W; de Villiers S; Pentel P; Zhang J; Dorn H; Ehrich M; Zhang C
    J Biomed Nanotechnol; 2015 Dec; 11(12):2197-210. PubMed ID: 26510313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and characterization of a new carrier for vaccine delivery based on calcium-alginate nanoparticles: Safe immunoprotective approach against scorpion envenoming.
    Nait Mohamed FA; Laraba-Djebari F
    Vaccine; 2016 May; 34(24):2692-9. PubMed ID: 27109567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunological evaluation of a DNA cocktail vaccine with co-delivery of calcium phosphate nanoparticles (CaPNs) against the Toxoplasma gondii RH strain in BALB/c mice.
    Rahimi MT; Sarvi S; Sharif M; Abediankenari S; Ahmadpour E; Valadan R; Ramandie MF; Hosseini SA; Daryani A
    Parasitol Res; 2017 Feb; 116(2):609-616. PubMed ID: 27909791
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The frequency of early-activated hapten-specific B cell subsets predicts the efficacy of vaccines for nicotine dependence.
    Laudenbach M; Tucker AM; Runyon SP; Carroll FI; Pravetoni M
    Vaccine; 2015 Nov; 33(46):6332-9. PubMed ID: 26409811
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Synthetic Nanoparticle Based Vaccine Approach Targeting MSP4/5 Is Immunogenic and Induces Moderate Protection Against Murine Blood-Stage Malaria.
    Wilson KL; Pouniotis D; Hanley J; Xiang SD; Ma C; Coppel RL; Plebanski M
    Front Immunol; 2019; 10():331. PubMed ID: 30930890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Freeze-thaw stress of Alhydrogel ® alone is sufficient to reduce the immunogenicity of a recombinant hepatitis B vaccine containing native antigen.
    Clapp T; Munks MW; Trivedi R; Kompella UB; Braun LJ
    Vaccine; 2014 Jun; 32(30):3765-71. PubMed ID: 24856785
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Matrix-M™ adjuvant enhances immunogenicity of both protein- and modified vaccinia virus Ankara-based influenza vaccines in mice.
    Magnusson SE; Altenburg AF; Bengtsson KL; Bosman F; de Vries RD; Rimmelzwaan GF; Stertman L
    Immunol Res; 2018 Apr; 66(2):224-233. PubMed ID: 29594879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nanoparticle vaccines.
    Zhao L; Seth A; Wibowo N; Zhao CX; Mitter N; Yu C; Middelberg AP
    Vaccine; 2014 Jan; 32(3):327-37. PubMed ID: 24295808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nanoparticles as Adjuvants in Vaccine Delivery.
    Garg A; Dewangan HK
    Crit Rev Ther Drug Carrier Syst; 2020; 37(2):183-204. PubMed ID: 32865905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new adjuvanted nanoparticle-based H1N1 influenza vaccine induced antigen-specific local mucosal and systemic immune responses after administration into the lung.
    Neuhaus V; Chichester JA; Ebensen T; Schwarz K; Hartman CE; Shoji Y; Guzmán CA; Yusibov V; Sewald K; Braun A
    Vaccine; 2014 May; 32(26):3216-22. PubMed ID: 24731807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-nicotine vaccines: Comparison of adjuvanted CRM197 and Qb-VLP conjugate formulations for immunogenicity and function in non-human primates.
    McCluskie MJ; Thorn J; Gervais DP; Stead DR; Zhang N; Benoit M; Cartier J; Kim IJ; Bhattacharya K; Finneman JI; Merson JR; Davis HL
    Int Immunopharmacol; 2015 Dec; 29(2):663-671. PubMed ID: 26404190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angelica sinensis polysaccharide encapsulated into PLGA nanoparticles as a vaccine delivery and adjuvant system for ovalbumin to promote immune responses.
    Gu P; Liu Z; Sun Y; Ou N; Hu Y; Liu J; Wu Y; Wang D
    Int J Pharm; 2019 Jan; 554():72-80. PubMed ID: 30399435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.